Nakamoto, Daisuke https://orcid.org/0009-0007-9662-6997
Ohata, Emi
Yuda, Mayumi
Fukui, Nobuyuki
Makino, Nao
Kanamori, Rie
Aoki, Nozomi
Kanazawa, Akio
Mori, Hirotake
Nishizaki, Yuji
Yokokawa, Hirohide
Yano, Yuichiro
Naito, Toshio
Article History
Received: 13 September 2025
Accepted: 2 January 2026
First Online: 7 January 2026
Declarations
:
: This study was approved by the Institutional Review Board of Juntendo University School of Medicine’s IRB (Approval No. [E23-0338-M02]). Since the study used anonymized secondary data, the requirement for informed consent was waived.
: Not applicable. This manuscript does not contain any individual person’s data.
: Daisuke Nakamoto is employed by Gilead Sciences, Japan and Rie Kanamori is employed by Bristol Myers Squibb, Japan. However, Gilead Sciences and Bristol Myers Squibb Japan did not fund and were not involved in conducting this study. The other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.